Skip to main content
Signal8

EOM Pharmaceuticals Holdings, Inc. (IMUC)

EOM Pharmaceuticals Holdings, Inc., a clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States. The company’s lead compound is EOM613, a peptide nucleic-acid solution with both anti-inflammatory and pro-inflammatory broad spectrum cytokine effects that has completed Phase 2 clinical trials for the treatment of cancer cachexia, AIDS/cancer cachexia, HIV/AIDS, and rheumatoid arthritis, as well as in Phase ½ a clinical trial to treat infectious diseases, such as COVID-19. It also develops EOM 147, an investigational broad-spectrum aminosterol with an intracellular mechanism that has completed Phase 2 clinical trial for the treatment of age-related macular degeneration, diabetic retinopathy, and macular edema due to retinal vain occlusion. EOM Pharmaceuticals Holdings, Inc. was founded in 2020 and is headquartered in Montvale, New Jersey.

Sector: Biotechnology

Industry: Biotechnology

EOM Pharmaceuticals Holdings, Inc. logo

EOM Pharmaceuticals Holdings, Inc.

OTC:IMUCHealthcare
-0.19%$0.1575
CLOSED
Mkt Cap$19.92M
EV$21.65M
Float112.95M
O/S126.5M
VOL6K sh
$ Vol$402
RVOL1.80×
Inst Own-
SI<0.1%
Net Cash/Sh-$0.01
Dilution
EOM Pharmaceuticals Holdings, Inc. logoOTC:IMUCClosed$0.1575-0.19%
Financials Summary
Revenue$0
Net Income-$1.92M
Total Assets$99K
Free Cash Flow-$1.49M
Debt & Equity
Total Debt$1.76M
Total Equity-$2.39M
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
  1. 1:10Reverse split
    Sep 16, 202010 shares → 1
  2. 1:40Reverse split
    Nov 21, 201640 shares → 1
Balance Sheet Details
Assets$99K
Liabilities$2.49M
Accounts Receivable$0
Accounts Payable$226K
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$300K$0$0$0$0
YoY Growth-------------------
Cost of Revenue$0$0$0$0$0$0$48K$75K$36K$48K$50K$0$0$0$0$0$0$0$0
Gross Profit$0$0$0$0$0$0-$48K-$75K-$36K-$48K-$50K$0$0$0$300K$0$0$0$0
Gross Margin--------------100.0%----
Research and Development$844K$937K$581K$1.23M$1.3M$697K$17.13M$19.11M$10.9M$5.97M$5.34M$7.71M$4.99M$2.29M$963K$1.3M$78K$772K$153K
Selling, General, and Administrative$984K$1.07M$1.24M$1.66M$1.31M$756K$4.03M$5.01M$4.62M$3.89M$4.12M$4.12M$3.64M$2.84M$1.99M$1.88M$2.24M$4.56M$54K
Other$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Operating Expenses$1.83M$2.01M$1.82M$2.89M$2.61M$1.45M$21.15M$24.11M$15.51M$9.86M$9.46M$11.83M$8.63M$5.14M$2.95M$3.18M$2.32M$5.34M$207K
Operating Income (EBIT)-$1.83M-$2.01M-$1.65M-$2.89M-$2.61M-$1.45M-$21.15M-$24.11M-$15.51M-$9.86M-$9.46M-$11.83M-$8.63M-$5.14M-$2.65M-$3.18M-$2.32M-$5.37M-$207K
Operating Margin---------------882.8%----
Interest Expense$95K$963K$551K$211K$8K$0$883K$1.31M$134K$63K$0$397K$0$0$0$0$0$0$0
Interest Income$0$0$0$166K$8$0$5K$24K$20K$14K$17K$9K$4K$4K$22K$117K$162K$30K$0
Other Income (Expense)-$95K$114K-$64K$238K-$66K$0$6.84M$2.03M$2.72M$481K$660K-$2.67M$0$0$22K$0-$1.29M$117K-$39K
Income Before Tax (EBT)-$1.92M-$1.89M-$1.72M-$2.65M-$2.68M-$1.45M-$14.31M-$22.09M-$12.79M-$9.38M-$8.8M-$14.5M-$5.72M-$6.15M-$2.63M-$3.06M-$3.61M-$5.22M-$246K
Income Tax Expense$0$0-$168K$0$0$0$0$0$0$15K-$50K$0-$2.91M$1.01M-$22K-$117K$0-$65K$0
Net Income-$1.92M-$1.89M-$1.61M-$2.65M-$2.68M-$1.45M-$18.52M-$23.4M-$12.92M-$9.39M-$8.75M-$14.5M-$5.72M-$6.15M-$2.63M-$3.06M-$3.61M-$5.15M-$246K
Net Income Margin---------------875.4%----
Supplementary Data
EPS-0.02-0.02-0.01-0.02-0.06-0.03-4.42-83.60-59.29-64.10-64.48-112.58-83.35-128.21-76.57-97.60-133.22-236.02-14.33
Diluted EPS-0.02-0.02-0.01-0.02-0.06-0.03-4.42-83.60-59.29-64.10-64.48-112.58-83.35-128.21-76.57-97.60-133.22-236.02-14.33
Weighted Average OS126.50M115.10M113.27M113.27M45.43M45.08M4.19M279,888218,009146,524135,702128,75268,62647,97134,29931,35027,13321,83217,169
EBITDA-$1.83M-$929K-$999K-$2.21M-$1$0-$13.38M-$20.2M-$12.53M-$9.33M-$8.75M-$14.45M-$5.7M-$6.15M-$2.62M-$3.06M-$864K-$5.15M-$246K
EBITDA Margin---------------874.3%----
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
Assets
Current Assets
Cash and Cash Equivalents$30K$99K$278K$613K$1.49M$263K$6.63M$11.44M$22.6M$23.22M$27.65M$26.22M$6.65M$5.32M$331K$85K$5.04M$1.06M$31K
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$1.08M$3M$0$0$0
Cash and Short-Term Investments$30K$99K$278K$613K$1.49M$263K$6.63M$11.44M$22.6M$23.22M$27.65M$26.22M$6.65M$5.32M$1.41M$3.09M$5.04M$1.06M$31K
Accounts Receivable$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Inventory$0$0$0$0$0$0$0$1.19M$1.16M$0$0$0$0$0$0$0$0$0$0
Other Current Assets$70K$248K$7K$0$0$0$379K$791K$797K$1.22M$763K$715K$91K$24K$22K$28K$30K$9K$1.33M
Total Current Assets$99K$347K$409K$769K$1.67M$263K$7.01M$13.41M$24.56M$24.44M$28.41M$26.93M$6.74M$5.34M$1.43M$3.11M$5.07M$1.07M$1.36M
Long-Term Assets
Property, Plant & Equipment Net$0$0$0$0$0$0$568$110K$181K$47K$66K$76K$76K$12K$5K$8K$0$0$40K
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$43K$66K$0$0$4K$0$3.37M$5.34M$689K$465K$12K$330K$9K$38K$7K$100$100$3K
Total Long-Term Assets$0$43K$66K$0$0$4K$568$3.48M$5.52M$736K$531K$88K$406K$21K$44K$15K$100$100$43K
Other Assets$0$0-$66K$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$99K$390K$409K$769K$1.67M$267K$7.01M$16.89M$30.08M$25.18M$28.94M$27.02M$7.15M$5.37M$1.47M$3.13M$5.07M$1.07M$1.4M
Liabilities
Current Liabilities
Accounts Payable$226K$0$0$0$0$0$1.77M$1.34M$1.16M$322K$861K$733K$1.32M$171K$226K$133K$30K$75K$15K
Short-Term Debt$437K$442K$4.37M$2.85M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Liabilities$88K$566K$1.29M$820K$0$0$296K$787K$318K$633K$184K$56K$319K$0$0$0$0$0$1.32M
Total Current Liabilities$1.17M$1.01M$5.65M$3.67M$465K$137K$2.36M$3.24M$2.27M$1.29M$1.4M$1.1M$1.76M$447K$376K$188K$73K$103K$1.38M
Long-Term Liabilities
Long-Term Debt$1.32M$0$369K$620K$2.82M$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$78K$670K$0$0$0$7.52M$6.09M$598K$1.06M$2.85M$2.16M$2.58M$0$0$0$777K$0
Total Long-Term Liabilities$1.32M$0$447K$1.29M$2.82M$0$0$7.52M$6.09M$598K$1.06M$2.85M$2.16M$2.58M$0$0$0$777K$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$2.49M$1.01M$6.1M$4.96M$3.28M$137K$2.36M$10.76M$8.36M$1.89M$2.47M$3.95M$3.92M$3.03M$376K$188K$73K$880K$1.38M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$100$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$13K$13K$11K$11K$11K$5K$4K$344$9K$6K$6K$5K$3K$2K$15K$13K$12K$8K$7K
Retained Earnings-$14.78M-$12.86M-$10.97M-$9.25M-$6.6M-$1.45M-$116.44M-$96.22M-$74.14M-$61.35M-$51.97M-$43.17M-$28.67M-$22.95M-$14.71M-$12.08M-$9.03M-$5.41M-$258K
Comprehensive Income & Other$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Stockholders' Equity$12.37M$12.23M$5.26M$5.05M$4.97M$1.58M$121.09M$102.35M$95.85M$84.63M$78.44M$66.23M$31.9M$25.29M$15.79M$15.01M$14.01M$5.59M$271K
Total Equity-$2.39M-$618K-$5.69M-$4.19M-$1.62M$130K$4.65M$6.13M$21.72M$23.29M$26.47M$23.07M$3.23M$2.34M$1.1M$2.94M$5M$190K$20K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$99K$390K$409K$769K$1.67M$267K$7.01M$16.89M$30.08M$25.18M$28.94M$27.02M$7.15M$5.37M$1.47M$3.13M$5.07M$1.07M$1.4M
Supplementary Data
Total Debt$1.76M$442K$4.74M$3.47M$2.82M$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Debt$1.73M$343K$4.46M$2.85M$1.33M-$263K-$6.63M-$11.44M-$22.6M-$23.22M-$27.65M-$26.22M-$6.65M-$5.32M-$331K-$85K-$5.04M-$1.06M-$31K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
Operating Activities
Net Income-$1.92M-$1.89M-$1.61M-$2.65M-$2.68M-$1.45M-$14.31M-$22.09M-$12.79M-$9.38M-$8.8M-$14.5M-$5.72M-$6.15M-$2.63M-$3.06M-$3.61M-$5.15M-$246K
Depreciation & Amortization$0$0$0$0$2.61M$1.94M$48K$75K$36K$48K$50K$46K$20K$4K$3K$2K$0$0$0
Deferred Income Tax$0$0$0$0$0$0$2.35M$0$0-$530K$4K$0$0-$1K-$308K$0$0$0$0
Stock-Based Compensation$0$0$0$0$0$0$492K$1.23M$916K$654K$724K$496K$1.19M$746K$308K$513K$0$4.1M$0
Changes in Working Capital:
  Accounts Receivable$0$0$0$0$0$0-$1.57M$789K$0$0$0$0$0$0$0$0$0$0$0
  Inventory$0$0$0$0$0$0$146K-$222K-$2.21M$0$0$0$0$0$0$0$0$0$0
  Accounts Payable$169K$0$0$0$0$0$491K$125K$805K-$645K$128K-$401K$963K-$55K$93K$103K$0$60K$15K
  Other Working Capital$221K-$345K$493K$379K$333K$137K$2.51M$2.23M-$5.3M-$150K-$251K-$703K$63K$123K$70K$7K-$50K$43K$39K
Total Working Capital Change$391K-$345K$493K$379K$333K$137K$1.59M$2.92M-$4.5M-$794K-$123K-$1.1M$1.03M$68K$163K$110K-$50K$43K$39K
Other Non-Cash Items$38K-$443K-$302K-$355K-$2.57M-$1.86M-$6.84M-$2M-$2.7M$63K-$642K$2.68M-$8.62M$1.08M$308K$489K$2.75M$4.58M$153K
Net Cash from Operating-$1.49M-$2.68M-$1.42M-$2.62M-$2.31M-$1.24M-$16.67M-$19.86M-$19.04M-$9.94M-$8.79M-$12.38M-$6.38M-$4.25M-$2.15M-$1.95M-$912K-$528K-$55K
Investing Activities
Capital Expenditures$0$0$4$0$0$0$0-$4K-$170K-$29K-$44K-$10K-$84K-$11K-$813-$10K$0$0-$40K
Acquisitions$0$0$0$0$0$0$1K$0$0$400$0$0$0$0$0$0$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$1.08M$1.92M-$3M$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$1.08M$1.92M$0$0$0$0
Other Investing Activities$0$0-$4$0$0$0$0$0$0$400$0$0$0$0$0$0$0$0$0
Net Cash from Investing$0$0$0$0$0$0$1K-$4K-$170K-$29K-$44K-$10K-$84K$1.07M$1.92M-$3.01M$0$0-$40K
Financing Activities
Debt Repaid-$1.43M-$2.5M-$1.09M-$1.75M-$2.5M--------$53K------
Common Stock Issuance$0$0$0$0$0$1.5M$11.86M$7.04M$14.6M$4.5M$4.91M$28.73M$7.36M$4.37M$0$489K$4.89M$1.56M$125K
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$0$0$0$1.03M$0$7.82M$1.66M$3.99M$1.04M$5.36M$3.22M$388K$27K$475K$0$0$0-$101
Net Cash from Financing$1.43M$2.5M$1.09M$1.75M$3.53M$1.5M$11.86M$8.7M$18.59M$5.54M$10.26M$31.95M$7.8M$8.18M$475K$0$4.89M$1.56M$125K
Forex Effect$0$0$0$0$0-$6.63M$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash-$69K-$180K-$335K-$873K$1.22M-$6.37M-$4.81M-$11.17M-$618K-$4.42M$1.43M$19.56M$1.33M$4.99M$246K-$4.96M$3.98M$1.03M$30K
Supplementary Data
Operating Cash Flow-$1.49M-$2.68M-$1.42M-$2.62M-$2.31M-$1.24M-$16.67M-$19.86M-$19.04M-$9.94M-$8.79M-$12.38M-$6.38M-$4.25M-$2.15M-$1.95M-$912K-$528K-$55K
Capital Expenditure-$3-$5$4$0$5$0$0-$4K-$170K-$29K-$44K-$10K-$84K-$11K-$813-$10K$0$0-$40K
Free Cash Flow-$1.49M-$2.68M-$1.42M-$2.62M-$2.31M-$1.24M-$16.67M-$19.87M-$19.21M-$9.97M-$8.83M-$12.39M-$6.47M-$4.26M-$2.15M-$1.96M-$912K-$528K-$95K
Cash at Beginning$99K$278K$613K$1.49M$263K$6.63M$11.44M$22.6M$23.22M$27.65M$26.22M$6.65M$5.32M$331K$85K$5.04M$1.06M$31K$101
Cash at End$30K$99K$278K$613K$1.49M$263K$6.63M$11.44M$22.6M$23.22M$27.65M$26.22M$6.65M$5.32M$331K$85K$5.04M$1.06M$31K